-transparent.png){kind=logo}
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma and has a poor prognosis. It needs prompt recognition in order to institute timely treatment. Given its relatively low incidence, it is an evolving area of research as well. This case report describes a patient with PCL in the setting of a previously treated myeloma. The report also reviews the clinicopathologic, cytogenetic, and immunophenotypic characteristics of PCL and its management.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Neeraja Swaminathan, and
Gabor Varadi
August 1989,
Singapore medical journal,
Neeraja Swaminathan, and
Gabor Varadi
July 2003,
Indian journal of pathology & microbiology,
Neeraja Swaminathan, and
Gabor Varadi
December 1950,
Revista medica cubana,
Neeraja Swaminathan, and
Gabor Varadi
January 1950,
Archivos cubanos de cancerologia,
Neeraja Swaminathan, and
Gabor Varadi
January 1961,
Israel medical journal,
Neeraja Swaminathan, and
Gabor Varadi
July 2005,
La Tunisie medicale,
Neeraja Swaminathan, and
Gabor Varadi
September 1976,
Minerva medica,
Neeraja Swaminathan, and
Gabor Varadi
July 2006,
Indian journal of pathology & microbiology,
Neeraja Swaminathan, and
Gabor Varadi
January 2012,
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
Neeraja Swaminathan, and
Gabor Varadi
July 2020,
Annals of palliative medicine,
